Why must filler type be verified before dissolution? Does hyaluronidase dissolve every filler?

Hyaluronidase can break down hyaluronic acid; it is not a universal antidote for calcium hydroxylapatite, poly-L-lactic acid, PMMA, silicone or unknown permanent materials. Attempted 'dissolution' without knowing the product can complicate diagnosis and risk planning.

This translation has no recorded clinical or medical-language review.

Direct answer

Hyaluronidase targets hyaluronic acid; filler materials are not interchangeable.
Swelling or a nodule is not always excess filler; infection, inflammation and oedema belong in the differential assessment.
Product label, lot record, injection plane and date may change the management options.

Identify the material first

Temporary, biostimulatory and permanent materials are marketed under the filler label. FDA information notes that removing permanent or non-HA products may be difficult or impossible. When old records are absent, make, contents, date and area should be investigated; appearance alone cannot establish the material.

Why the cause of a symptom matters

Asymmetry, hardness, redness or delayed swelling may relate to infection, inflammatory reaction, foreign-body response, a vascular problem or another condition rather than excess product. Even when hyaluronidase is considered for HA, it has risks including allergic reaction and tissue change; it is not a blind diagnostic trial.

Records used in assessment

Document product label and lot, quantity, injection plane, date, previous hyaluronidase or filler, dental work, infection and systemic symptoms. Examination and appropriate imaging may help locate material. Acute vascular or visual symptoms are emergencies distinct from routine aesthetic correction.

Scope of this article

This content is not diagnosis, prescribing, personal risk assessment or a treatment plan. Sources may be limited to a particular product, device, task, indication or study group.

Sources and evidence limits

These links are editorial starting points used to examine the article's boundaries.

Dermal Fillers (Soft Tissue Fillers)
U.S. Food and Drug Administration (FDA) · 2023
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Guideline for the Management of Hyaluronic Acid Filler-Induced Vascular Occlusion
Gillian Murray, Cormac Convery, Lee Walker, Emma Davies; Complications in Medical Aesthetics Collaborative (CMAC) · 2021
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Safety and Potential Complications of Facial Wrinkle Correction with Dermal Fillers: A Systematic Literature Review
Audra Janovskiene, Deividas Chomicius, Dominykas Afanasjevas, Zygimantas Petronis, Dainius Razukevicius, Egle Jagelaviciene · 2024
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Rates of Vascular Occlusion Associated With Using Needles vs Cannulas for Filler Injection
M. Alam et al. · 2021
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Factors Influencing Pre-Injection Aspiration for Hyaluronic Acid Fillers: A Systematic Literature Review and Meta-Analysis
D. J. Casabona · 2020
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review